C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2004
11/17/2004	EP1477563A2 Cloning genes from streptomyces cyaneogriseus subsp.noncyanogenus for biosynthesis of antibiotics and methods of use
11/17/2004	EP1477562A1 Transcriptional factor, transcriptional factor gene, recombinant vector containing transcriptional factor gene, koji-mold transformed by the vector and method of using koji-mold
11/17/2004	EP1477561A2 Molecule assigning genotype to phenotype and use thereof
11/17/2004	EP1477560A1 Alga-origin promoter, intron and terminator
11/17/2004	EP1477558A1 Selection methods
11/17/2004	EP1477557A1 transgenic plant resistant to mycotoxins and methods
11/17/2004	EP1477497A1 Humanized immunoglobulins and their production and use
11/17/2004	EP1477494A1 Subunit respiratory syncytial virus vaccine preparation
11/17/2004	EP1477185A2 Pneumococcal genes, portions thereof, expression products therefrom and uses of such genes, portions and products
11/17/2004	EP1476753A2 Functionalized compositions for improved immobilization
11/17/2004	EP1476751A2 Screening method
11/17/2004	EP1476750A1 Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of disseminated lupus erythematosus (dle)
11/17/2004	EP1476748A2 Gene function inferring using gene expression data
11/17/2004	EP1476747A2 Molecular hepatotoxicology modeling
11/17/2004	EP1476746A2 Method for discovering pharmacologically active substances
11/17/2004	EP1476582A1 Nucleotide sequence coding for a tolc containing a heterologous amino acid sequence
11/17/2004	EP1476581A2 Recombinant bovine immunodeficiency virus based gene transfer system
11/17/2004	EP1476580A2 Multiple virus replicon culture systems
11/17/2004	EP1476578A2 Mismatch repair detection
11/17/2004	EP1476577A2 Regulated vectors for controlling dna hypermutability in eukariotic cells
11/17/2004	EP1476575A2 Detection of single nucleotide polymorphisms using planar waveguides
11/17/2004	EP1476574A2 RNA INTERFERENCE MEDIATED INHIBITION OF TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (IGF-1R) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/17/2004	EP1476573A2 Crude biological derivatives competent for nucleic acid detection
11/17/2004	EP1476572A2 Digital amplification for detection of mismatch repair deficient tumor cells
11/17/2004	EP1476571A1 Complex comprising at least two biospecific elements separated by a nucleic acid linker e.g. for identification of drug delivery candidates. combinatorial library of such complexes
11/17/2004	EP1476570A2 Methods and means for identification of gene features
11/17/2004	EP1476569A2 Methods and means for manipulating nucleic acid
11/17/2004	EP1476567A1 A method for the diagnosis of lymphoproliferative diseases
11/17/2004	EP1476566A2 Method for detecting bacteria associated with parodontitis and tooth decay
11/17/2004	EP1476564A1 Cooperative oligonucleotides
11/17/2004	EP1476563A2 Method for the recombination of genetic elements
11/17/2004	EP1476562A2 Over-expression of extremozyme genes in pseudomonads and closely related bacteria
11/17/2004	EP1476561A2 Reducing non-target nucleic acid dependent amplifications: amplifying repetitive nucleic acid sequences
11/17/2004	EP1476560A2 Methods for the reduction of stutter in microsatellite amplification
11/17/2004	EP1476559A2 Process for producing levodione
11/17/2004	EP1476557A1 A rapid and sensitive assay for the detection and quantification of coregulators of nucleic acid binding factors
11/17/2004	EP1476556A2 Process for producing starch hydrolysate
11/17/2004	EP1476554A1 Novel compound for inhibiting serine proteases and for inhibiting viral infections or viral propagation: rld 8564
11/17/2004	EP1476553A2 Gene for peripheral arterial occlusive disease
11/17/2004	EP1476552A2 Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent
11/17/2004	EP1476551A2 Method for the identification of tissue-specific regulatory sequences
11/17/2004	EP1476550A1 Method of separation using aromatic thioether ligands
11/17/2004	EP1476549A1 Methods for two-dimensional conformation-dependent separation of non-circular nucleic acids
11/17/2004	EP1476548A2 Process of cell electrofusion
11/17/2004	EP1476547A2 Targeted chromosomal mutagenesis using zinc finger nucleases
11/17/2004	EP1476546A2 Functionalization of carotenoid compounds
11/17/2004	EP1476545A2 Aggrecanase molecules
11/17/2004	EP1476543A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
11/17/2004	EP1476541A2 Novel cytokine zcytor17 ligand
11/17/2004	EP1476539A2 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/17/2004	EP1476538A2 Chimeric bird from embryonic stem cells
11/17/2004	EP1476537A2 Container with at least one electrode
11/17/2004	EP1476492A1 Carbohydrate-modified polymers, compositions and uses related thereto
11/17/2004	EP1476469A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
11/17/2004	EP1476468A2 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity
11/17/2004	EP1476466A1 Management of mucosal viscosity by tff monomer peptides
11/17/2004	EP1476463A1 Mhc class i peptide epitopes from the human 5t4 tumor-associated antigen
11/17/2004	EP1476462A2 Novel fungal lipase
11/17/2004	EP1476461A2 Immune-modulating peptide made of s. aureus enterotoxin b
11/17/2004	EP1476460A2 A nucleic acid encoding a g-protein-coupled receptor; and uses thereof
11/17/2004	EP1476459A2 RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/17/2004	EP1476458A2 Rna interference mediated inhibition of platelet derived growth factor (pdgf) and platelet derived growth factor receptor (pdgfr) gene expression using short interfering nucleic acid (sina)
11/17/2004	EP1476457A2 RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYPROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SiNA)
11/17/2004	EP1476456A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/17/2004	EP1476407A2 Methods of producing phosphitylated compounds
11/17/2004	EP1476188A2 Method for accessing microbial diversity
11/17/2004	EP1476185A2 Antibodies to cd40
11/17/2004	EP1476182A1 Immunogenic formulations of variable peptidic epitopes and process for preparation thereof
11/17/2004	EP1476180A2 Interleukin-2 mutants with reduced toxicity
11/17/2004	EP1476153A2 Method of treating and preventing bone loss
11/17/2004	EP1476120A2 Treatment methods using anti-cd22 antibodies
11/17/2004	EP1476067A2 Novel compositions and methods for cancer
11/17/2004	EP1476012A1 Transgenic animals expressing prkag3
11/17/2004	EP1430153A4 Methods for detecting genetic mosaicisms using arrays
11/17/2004	EP1430111A4 Culture system for rapid expansion of human embryonic stem cells
11/17/2004	EP1379852A4 Multi-format sample processing devices, methods and systems
11/17/2004	EP1337543A4 Streptavidin-binding peptides and uses thereof
11/17/2004	EP1254229B1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof
11/17/2004	EP1252322B1 Herpes virus strains for gene therapy
11/17/2004	EP1252292A4 Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
11/17/2004	EP1223799A4 Non-transgenic herbicide resistant plants
11/17/2004	EP1203080B1 Isolation of biomolecules
11/17/2004	EP1196606B1 Lytic enzyme
11/17/2004	EP1178721A4 Process of rapid variety-independent plant transformation
11/17/2004	EP1159457A4 T cell receptor vbeta beta-jbeta) sequence and methods for its detection
11/17/2004	EP1115856B1 Method for making insertional mutations
11/17/2004	EP1105503B1 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1)
11/17/2004	EP1086205A4 Methods of monitoring disease states and therapies using gene expression profiles
11/17/2004	EP1073770B1 Novel method for the identification of clones conferring a desired biological property from an expression library
11/17/2004	EP1073733B1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
11/17/2004	EP1055125B1 Interaction between cyclin d1 and steroid receptor co-activators
11/17/2004	EP1040193B1 Promoter from ashbya gossypii
11/17/2004	EP1036085A4 Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics
11/17/2004	EP1002138B1 Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of hiv-1
11/17/2004	EP0990029A4 Phytochrome regulated transcription factor for control of higher plant development
11/17/2004	EP0988313A4 METHODS FOR RAPID CLONING OF FULL LENGTH cDNAs
11/17/2004	EP0943003B1 Insulin-like growth factor i (igf-i) expression system and methods of use
11/17/2004	EP0942928B1 Subunit respiratory syncytial virus vaccine preparation
11/17/2004	EP0939798B1 Antifungal proteins, dna coding therefore, and hosts incorporating same
11/17/2004	EP0928190B1 Nucleic acid particle delivery

1 ... 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 ... 4023